People with rheumatic disease who develop COVID-19 may be at risk of more severe disease, especially if they are on moderate- to high-dose glucocorticoids, a new study suggests. However, the review of COVID-19 outcomes for patients with immune-mediated inflammatory disease (IMID) found that they are otherwise not at higher risk of developing COVID-19 and most ...
Glucocorticoid use a risk factor for more severe outcomes in COVID-19
By Megan Howe
4 Aug 2020